Suppr超能文献

口服及阴道内使用前列腺素E2促进宫颈成熟及引产

Oral and intravaginal prostaglandin E2 for cervical ripening and induction of labour.

作者信息

Davey D A, Macnab M

出版信息

S Afr Med J. 1979 May 19;55(21):837-42.

PMID:472913
Abstract

The effect of prostaglandin E2 (PGE2) in 'ripening' the cervix was studied in 33 patients who required surgical induction of labour. Patients included primigravidas and parous subjects between 36 and 42 weeks of gestation. Sixteen patients received a total oral dose of 5 mg PGE2 and 17 received 4 - 6 mg PGE2 intravaginally in the form of a gel. There was significant improvement in 'ripeness' of the cervix in all groups, the intravaginal route giving slightly better results than the oral route. Ten patients remained unsuitable for induction because of inadequate dilatation of the cervix or a high fetal head. Four patients on oral therapy developed late decelerations of the fetal heart and 3 of these were delivered by immediate caesarean section. The implications of this and the reasons for the inability to perform inductions after 'ripening' are discussed.

摘要

在33例需要手术引产的患者中研究了前列腺素E2(PGE2)对宫颈“成熟”的作用。患者包括妊娠36至42周的初产妇和经产妇。16例患者口服PGE2总量为5mg,17例患者阴道内给予4 - 6mg凝胶形式的PGE2。所有组宫颈“成熟度”均有显著改善,阴道给药途径的效果略优于口服途径。10例患者因宫颈扩张不足或胎头高而仍不适合引产。4例口服治疗的患者出现胎儿心率晚期减速,其中3例立即行剖宫产分娩。本文讨论了这一情况的意义以及“成熟”后无法进行引产的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验